KAINOS LaboratoriesTSE:4556 39 FCF Margin % is 17.24% as of Mar. 2026, which is 72% above its 10-year median of 10.00. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, KAINOS Laboratories ranks better than 74.14% on this metric.
The historical rank and industry rank for KAINOS Laboratories's FCF Margin % or its related term are showing as below:
TSE:4556'
s FCF Margin % Range Over the Past 10 Years
Min: 3.8 Med: 10 Max: 13.52
Current: 9.96
During the past 13 years, the highest FCF Margin % of KAINOS Laboratories was 13.52%. The lowest was 3.80%. And the median was 10.00%.
TSE:4556's FCF Margin % is ranked better than 74.14% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.375
vs TSE:4556: 9.96
KAINOS Laboratories FCF Margin % Related Terms
KAINOS Laboratories FCF Margin % Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4556 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KAINOS Laboratories FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's FCF Margin % distribution charts can be found below:
* The bar in red indicates where KAINOS Laboratories's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAINOS Laboratories (TSE:4556) has a FCF Margin % of 17.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on KAINOS Laboratories and its competitors. This is 72% above median its historical median of 10.00. Over the past decade, KAINOS Laboratories' FCF Margin % has ranged from 3.80 to 13.52. According to the industry distribution chart, KAINOS Laboratories ranks #211 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 25.9%.
Is KAINOS Laboratories' FCF Margin % too high?
KAINOS Laboratories' current FCF Margin % of 17.24% is 72% above median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 3.80 to a high of 13.52. Based on the distribution chart, KAINOS Laboratories ranks #211 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #211 out of 816 companies for FCF Margin %. This puts KAINOS Laboratories in the upper half of its industry. Historically, KAINOS Laboratories' own FCF Margin % has ranged from 3.80 to 13.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on KAINOS Laboratories and its competitors. KAINOS Laboratories's current FCF Margin % is 17.24%, which is 72% above median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current FCF Margin % is 17.24%, which is 72% above median its 10-year median of 10.00. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current FCF Margin % is 17.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
FCF Margin %: 17.24% (72% above median its 10-year median of 10.00)
GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score
Get the complete analysis for TSE:4556
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
